Evolution of the Average Target: Shield Therapeutics plc

Evolution of the Target Price: Shield Therapeutics plc

Changes in Analyst Recommendations: Shield Therapeutics plc

95ff47ab2385.6yVEPSpOqXgCQ-DcqdQUGFIW8MvxzflS5-LprPZO-uQ.uxMbeEd_3zN4DY6z8bImKWVfgYy8j8hj0Ia5m8MDrJHfTgxXeQb4IWkSsQ~0500b9d3f77c61e1f94e31c612467e3d

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+21.06%
+20.33%
+47%
+12.23%
+9.86%
-21.93%
-2.93%
+32.1%
+7.12%
Average +13.87%
Weighted average by Cap. +17.17%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.0620GBP
Average target price
0.1667GBP
Spread / Average Target
+168.82%
High Price Target
0.2300GBP
Spread / Highest target
+270.97%
Low Price Target
0.1200GBP
Spread / Lowest Target
+93.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.0620GBP
Average target price
0.1667GBP
Spread / Average Target
+168.82%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STX Stock
  4. SHIEF Stock
  5. Consensus Shield Therapeutics plc